You are here: Industry Insights > COVID-19

News List

SLAs to issue manufacture/sale licenses for AYUSH formulations only after approval from AYUSH Ministry expresspharma
August 03, 2020
The move aims to generate proof of effectiveness for new indications and curb down the false claims associated with AYUSH-related research treatment mechanism.
COVID-19 panel recommends DCGI to permit SII to conduct human trials of Oxford vaccine candidate expresspharma
August 03, 2020
SII had submitted a revised proposal on Wednesday after the expert panel had asked it to revise its protocol for the trials besides seeking some additional information.
COVID-19 resurgence expected in US as herd immunity unlikely: GlobalData expresspharma
August 03, 2020
New data suggest that some hard-hit communities may be better protected for COVID-19 resurgence, while other communities are not.
Russia readying for mass vaccination against COVID-19 in October expresspharma
August 03, 2020
Health Minister, Mikhail Murashko said doctors and teachers would be the first to be vaccinated.
GSK sees dip in second-quarter sales pharmatimes
July 31, 2020
GlaxoSmithKline has reported group sales of ￡7.6 billion for the second quarter of 2020, marking a slip of 2% from a year ago, reflecting expected disruption from COVID-19.
Immunic Begins IMU-838, Oseltamivir Trial for COVID-19 americanpharmaceuticalreview
July 31, 2020
Immunic announced enrollment of the first patients in an investigator-sponsored phase 2 clinical trial of the company's selective oral DHODH inhibitor, IMU-838, for the treatment of patients with coronavirus disease 2019 (COVID-19).
FDA Authorizes Test for People without Known, Suspected COVID-19 Infection americanpharmaceuticalreview
July 31, 2020
The U.S. Food and Drug Administration (FDA) reissued the LabCorp COVID-19 RT-PCR Test emergency use authorization (EUA) to include two new indications for use ...
Onconova Submits Application for Rigosertib to Participate in COVID-19 Human Studies americanpharmaceuticalreview
July 31, 2020
Onconova Therapeutics has submitted an application with the National Institute of Allergy and Infectious Disease (NIAID), with the goal of obtaining funding from the National Institutes of Health (NIH) to conduct human studies with rigosertib in COVID-19.
COVID-19 rapid antibody tests approved for use in UK europeanpharmaceuticalreview
July 31, 2020
Abingdon Health’s COVID-19 rapid antibody test has been registered with the UK’s Medicines and Healthcare products Regulatory Agency.
Hetero launches generic favipiravir to treat Covid-19 in India pharmaceutical-technology
July 31, 2020
India-based Hetero Labs has launched a generic version of antiviral drug favipiravir, under the brand name Favivir, to treat Covid-19 patients in the country.